-
admin
Posts
Kick Off the New Year with the Momcozy Baby Registry Campaign: Win Exclusive Parenting Essentials
New York, NY, Jan. 14, 2025 (GLOBE NEWSWIRE) — Momcozy is excited to announce the launch of its very own Baby Registry System. The launch campaign...
Celebrating Over 15 Years of Partnership: Nüline Distribution as Fatboy’s Official Canadian Distributor
MONTREAL, Jan. 14, 2025 (GLOBE NEWSWIRE) — Nüline Distribution is proud to announce its enduring partnership as the official Canadian distributor for the iconic Dutch...
Leadership change fuels Busways’ strategic ambitions
SYDNEY, Jan. 15, 2025 /PRNewswire/ — Busways, the largest Australian-owned bus operator, has appointed Will O’Neill as its new Chief Executive Officer, effective January 1, 2025....
Nature’s Miracle Holding Inc. Announces Receipt of Delisting Notification from Nasdaq
ONTARIO, Calif., Jan. 15, 2025 /PRNewswire/ — Nature’s Miracle Holding Inc. (NASDAQ: NMHI) (“Nature’s Miracle” or the “Company”), a leader in vertical farming technology and...
Solidion Technology’s Chief Science Officer Delivers Keynote at Prestigious Advanced Materials Summit in Abu Dhabi
Dr. Bor Jang Showcases Graphene’s Transformative Potential for Next-Generation Energy Storage Solutions DAYTON, Ohio, Jan. 15, 2025 /PRNewswire/ — Solidion Technology, Inc. (NASDAQ: STI), an advanced...
Verkada Expands Leadership Team to Drive JAPAC Channel Growth
Boudewijn Pesch Joins Verkada as Vice President of JAPAC Channel Sales SAN MATEO, Calif., Jan. 15, 2025 /PRNewswire/ — Verkada, a leader in cloud-based physical...
Supermicro Empowers AI-driven Capabilities for Enterprise, Retail, and Edge Server Solutions
Retailers Can Leverage AI to Increase Revenue and Reduce Costs with Supermicro and NVIDIA‘s Collaboration SAN JOSE, Calif. and NEW YORK, Jan. 15, 2025 /PRNewswire/ —...
Instil Bio Announces Clinical Progress in China for IMM2510/SYN-2510, a Clinical-Stage PD-L1xVEGF Bispecific Antibody
ImmuneOnco announced dosing of first patient in its recently initiated Phase 1b/2 clinical trial of IMM2510/SYN-2510 in combination with chemotherapy in patients with advanced NSCLC...
Umoja Biopharma Announces Oversubscribed $100 Million Series C Financing to Advance In Vivo CAR T Pipeline through Key Oncology Clinical Milestones
Series C financing co-led by Double Point Ventures and DCVC Bio Proceeds to support the clinical development of VivoVec™ derived in vivo CAR T cells...
Ocular Therapeutix™ Shares SOL-R Enrollment Progress and Next Steps for AXPAXLI™ in NPDR
311 subjects enrolled across various stages of loading and randomization in SOL-R, Ocular’s second registrational trial of AXPAXLI™ in wet AMD, as of January 10,...
